SELECTIVE ANTIBODIES LIMITED
Significant control: Professor Colin Henry Self (50–75%)
From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms
Watch this company
Get an email when Companies House records a change for Selective Antibodies Limited: status, filings, accounts, officers or owners. Free.
Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy
What does Selective Antibodies Limited sell?
Registered activity: Research and experimental development on biotechnology (SIC 72110). We’re building product and service lists for UK companies. Get this one when it’s ready.
Summary
SELECTIVE ANTIBODIES LIMITED is an active private limited company (company number 02575564) incorporated on 21 January 1991, registered in Newcastle Upon Tyne. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest micro accounts cover the period ending 30 November 2025, showing net assets of £54k, with 0 employees on average. As micro-entity accounts, no profit and loss account is filed, so turnover and profit are not public. Net assets rose 407% on the prior period (£11k). Across the last 3 periods on record the net-asset trend is volatile.
By net assets it sits in the upper half of 2,418 comparable companies in the UK (median £1,000, upper quartile £92k).
Ownership and control
- Professor Colin Henry Self
- owns 50–75% of shares
- holds 50–75% of voting rights
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.
Key dates
- Incorporated
- 21 January 199135 yrs ago
- Next accounts due
- 30 August 2027in 307 days
- Confirmation statement due
- 4 February 2027in 100 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Micro Entity
- Size band
- MicroCompanies Act thresholds
Financials
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 November 2025 | £54k | — | — | £10k | — | — | 0 |
| 30 November 2024 | £11k | — | — | £3,160 | — | — | 0 |
| 30 November 2023 | £15k | — | — | £15 | — | — | 0 |
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing; micro-entity accounts contain no profit and loss account.
Filing and accounts signals
- Net assets above zeroNet assets £53,967 at 30 November 2025
- Net assets up 10% or more on the prior period+406.6% vs prior period
- Current assets at least 1.5× creditors within one yearCurrent ratio 5.27
- Three or more accounting periods on record3 periods on record
- Incorporated five or more years agoIncorporated 21 January 1991
Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.
Timeline
- Next accounts duein 307 days
- Confirmation statement duein 100 days
- Accounts period endNet assets £54k · micro accounts
- Accounts period endNet assets £11k · micro accounts
- Accounts period endNet assets £15k · micro accounts
- Incorporated
Similar companies in Newcastle
- HUGO (LONDON)Newcastle Upon Tyne · inc. Mar 1990
- COMPLEMENT GENOMICS LIMITEDDurham · inc. Feb 2000
- EPITOPE INFORMATICS LIMITEDHexham · inc. Mar 2000
- AEIRTEC LTDNorth Shields · inc. Sept 2003
- MDNA LIFE SCIENCES (UK) LTDNewcastle Upon Tyne · inc. Mar 2005
- OPTIMUM SCIENTIFIC LIMITEDMorpeth · inc. Nov 2007
All companies incorporated on 21 January 1991 · in Jan 1991.
Reminders for SELECTIVE ANTIBODIES LIMITED
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.